Intellectual Property

  • April 17, 2026

    OpenAI Drops 9th Circ. Appeal Over 'Cameo' TM Block

    OpenAI has abandoned its Ninth Circuit appeal of an injunction blocking it from using the term "Cameo" in relation to a component of its artificial intelligence video generator Sora 2.

  • April 17, 2026

    WDTX Jury Clears Bitcoin Mining Co. In Patent Suit

    A federal jury in the Western District of Texas let bitcoin mining company Riot Platforms off the hook Friday when it found the company didn't infringe a patent owned by Green Revolution Cooling Inc. covering ways to cool down electronics at data centers.

  • April 17, 2026

    Google Wins Ax Of Last Targeted Ad Patent Claim In Suit

    A Delaware federal judge has found the sole remaining claim in a targeted advertising software patent Google was accused of infringing is invalid, saying it is abstract and doesn't cover an inventive idea.

  • April 17, 2026

    Denver Food Truck Biz Says Rival Stole Secrets Via Sham Deal

    A Denver food truck business has claimed its would-be partners stole its operational playbook and then threatened its owner and employees, according to a lawsuit filed in Colorado state court.

  • April 17, 2026

    Denver Bookshop Says 'Book Society' Can't Be A Trademark

    A Denver independent bookstore asked a Colorado federal judge Friday to declare it is not infringing upon a California book and wine lounge or engaging in unfair competition by using "book society" in its name.

  • April 17, 2026

    HyperSphere Beats Tech IP Suit, Falters On Sanctions Bid

    Georgia-based cybersecurity firm HyperSphere Technologies Inc. on Friday escaped a suit alleging infringement of a developer's copyrighted software code but was denied a request for sanctions for having to defend itself from what it called a "frivolous" lawsuit.

  • April 17, 2026

    Rapper Says Coach Ripped Off 'This Is A Blue T-Shirt' Mark

    Los Angeles rapper G Perico alleges in a California federal lawsuit that luxury brand Coach has infringed his "this is a blue t-shirt" trademark and brand by selling shirts that bear the slogan "this is a Coach t-shirt."

  • April 17, 2026

    PTAB To Eye 3 Patents After Squires Rejected TikTok Reviews

    The Patent Trial and Appeal Board has agreed to launch reviews of whether three Cellspin Soft Inc. patents for publishing data on websites are invalid after the company was able to dodge earlier challenges from TikTok.

  • April 17, 2026

    Deer Feed Co. Fights Blockbuster's 'Block Buster' TM Claims

    A Mississippi animal feed company has asked federal trademark judges to throw out Blockbuster LLC's bid to block an application for "Block Buster" for deer feed supplements, arguing the defunct video rental giant failed to clearly identify which of its many registrations are allegedly being infringed or diluted.

  • April 17, 2026

    'Lion King' Suit May Not Reign In Podcasting Legal Jungle

    A recently filed suit over the alleged mischaracterization of the iconic opening chant in “The Lion King” may not hold up in court, but the case highlights the risks podcasters can face in a freewheeling and increasingly ubiquitous medium, experts say.

  • April 17, 2026

    Life Sciences Firm Says Ex-VP Took Trade Secrets To Rival

    A Massachusetts life sciences startup says a former vice president who left the company last fall, purportedly to care for his ill wife, instead took trade secrets with him to a new job at a California rival.

  • April 17, 2026

    Polsinelli Sent Bogus Infringement Letters, Suits Say

    National law firm Polsinelli PC was accused of sending letters to two medical device companies with meritless claims of patent infringement, the companies claimed in a pair of malpractice suits.

  • April 17, 2026

    USPTO Extends AI-Based Search Pilot Program

    The U.S. Patent and Trademark Office has announced it will extend its Artificial Intelligence Search Automated Pilot Program, launched last year to allow applicants and examiners to search for prior art, until June 1 in order to obtain more information on the program's effectiveness.

  • April 17, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen Aston Martin file an appeal in a row with Chinese carmaker Geely over its winged logo for London black cabs, Ineos sue Ben Ainslie's America's Cup team for a £180 million ($244 million) boat, White & Case face a claim from two energy storage companies, and a golf tour company bring a claim against Saudi Arabia's sovereign wealth fund after the fund invested in its rival.

  • April 17, 2026

    Fed. Circ. Reverses $18M Penile Implant Trade Secret Win

    In a unanimous precedential decision, the Federal Circuit on Friday largely reversed a California jury's $18.3 million trade secret verdict over a penile implant, holding that the asserted secrets were already publicly disclosed or generally known and therefore not protectable.

  • April 16, 2026

    Nvidia Fights Uphill For Big Trim Of Authors' AI Copyright Suit

    A California federal judge indicated Thursday that he won't grant Nvidia Corp.'s request to permanently toss the bulk of a proposed class action by authors who say the artificial intelligence giant unlawfully copied their copyrighted material to develop its LLMs, but will pare some claims with leave to amend.

  • April 16, 2026

    Ex-ByteDance Exec Fights Perjury Sanction At 9th Circ.

    A former ByteDance executive urged the Ninth Circuit Thursday to revive a suit he filed against the TikTok owner after he was fired, saying the case should've been heard in state court and a federal judge had no jurisdiction to order terminating sanctions after finding he perjured himself.

  • April 16, 2026

    ITC Told Wrongly Claimed Patent Fee Discounts Sink Chip Suit

    Semiconductor company Everspin Technologies Inc. has asked the U.S. International Trade Commission to end a memory chip patent suit against it by Avalanche Technology Inc., saying Avalanche's patents are unenforceable because the company wrongly claimed a "small entity" discount on patent fees for years.

  • April 16, 2026

    Ramey Says Sanctions Violation Was 'Misunderstanding'

    William Ramey, an intellectual property attorney sanctioned in several federal jurisdictions, told a California federal judge Thursday that any violations of a previous sanctions order regarding his ability to practice law in the state were due to "good-faith misunderstanding of the scope of the court's order — not willful disregard."

  • April 16, 2026

    SAP Owes $17M In Software Patent Case, Jury Finds

    A jury in the Eastern District of Texas said Thursday afternoon that SAP America Inc. owes $17 million after finding that the company infringed a pair of software patents owned by Cyandia Inc., including one SAP had unsuccessfully challenged at the Patent Trial and Appeal Board.

  • April 16, 2026

    Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

    The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents, finding that contrary to the judge's finding, the patents are not invalid.

  • April 16, 2026

    IV Device Redesign Not Enough To Lift Ban, CBP Says

    A U.S. medical device company's redesigned products used for intravenous drips are still barred from importation into the country, U.S. Customs and Border Protection said in an order released Thursday, with the agency unconvinced the new versions aren't still patent-infringing.

  • April 16, 2026

    Hyundai Tech Owes Hyundai Motor $2.5M In TM Case

    A small U.S. computer company called Hyundai Technology has been told to pay $2.5 million by a California federal jury to Korean automaker Hyundai Motor Co. after being accused of "piggybacking" off of the auto giant's trademark and causing confusion for consumers.

  • April 16, 2026

    USPTO Ends COVID Patent Appeals Program

    The U.S. Patent and Trademark Office has decided to end a program launched five years ago that aimed to prioritize and fast-track ex parte appeals of rejections on patent applications for inventions related to combating COVID-19.

  • April 16, 2026

    Fed. Circ. Snubs Early Appeal In Camera Tech Patent Feud

    The Federal Circuit on Thursday denied U.S. Navy contractor FullView Inc.'s request to appeal a California federal judge's invalidation of claims in its camera technology patent for not meeting eligibility requirements and the exclusion of a damages expert's testimony in litigation against HP unit Polycom.

Expert Analysis

  • Considering The Risks That Arise When IP Outlives Its Owner

    Author Photo

    Federal and state court decisions show that the statutory regime for each category of intellectual property promises continuity after the owner's death, but the law does not provide a succession framework for how those rights are to be exercised, says Erin Daly at Daly Law & Strategy.

  • How A High Court Music Piracy Ruling Shrinks ISP Liability

    Author Photo

    The U.S. Supreme Court's recent opinion in Cox Communications Inc. v. Sony Music Entertainment, which concerned the boundaries of contributory copyright infringement for internet service providers, dramatically lessens both the risk that an ISP will be held contributorily liable and, relatedly, the incentives an ISP may have to help combat online copyright infringement, say attorneys at Debevoise.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • Opinion

    USPTO Has A Chance To Correct Double-Patenting Doctrine

    Author Photo

    Now that the issue of obviousness-type double patenting is front and center before the U.S. Patent and Trademark Office's Appeals Review Panel, the agency should put an end to the practice of rejecting earlier-expiring patents in favor of later-expiring ones, say attorneys at Orrick.

  • 1st AI Acquisition Regulation Raises Contractor Concerns

    Author Photo

    The General Services Administration’s recently published contract clause addressing artificial intelligence systems is problematic in a number of ways, underscoring the complex legal and practical issues that will need to be addressed as AI becomes more widely deployed in federal contracting, say attorneys at Haynes Boone.

  • Grammarly Suit Flags Right Of Publicity As Key AI Issue

    Author Photo

    Angwin v. Superhuman Platform, filed recently in New York federal court against the parent company of Grammarly, highlights an overlooked question for any company using artificial intelligence — whether someone's identity has been used for commercial purposes without consent, possibly violating rapidly shifting state right-of-publicity laws, says Nicholas Schneider at Eckert Seamans.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • Reel Justice: 'Mercy' And Private Surveillance As Evidence

    Author Photo

    The near-future depicted in the film “Mercy” reminds attorneys that private surveillance networks are becoming central to the evidentiary ecosystem, shaping what prosecutors can obtain, what defendants must explain and what jurors may interpret as objective truth, says Veronica Finkelstein at Wilmington University.

  • Fed. Circ. In February: When Grammar Trumps Patent Specs

    Author Photo

    The Federal Circuit's decision in Netflix v. DivX last month highlights the challenge of interpreting potentially misplaced modifiers in complicated technological patents, and the potential for grammatical rules to provide a default interpretation for unclear claim language, say attorneys at Knobbe Martens.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

  • When Trade Secret Litigation And Criminal Law Collide

    Author Photo

    An increasing convergence of trade secret litigation and white collar defense, especially with several recent criminal prosecutions from the Justice Department, should prompt businesses and counsel to adapt within the overlapping landscapes, says Kenneth Notter at MoloLamken.

  • Opinion

    PTAB Needs Reform To Protect Inventors From Larger Cos.

    Author Photo

    The Promoting and Respecting Economically Vital American Innovation Leadership Act is necessary because it will impose additional requirements on patent validity challenges and prevent large corporations from taking advantage of the Patent Trial and Appeal Board to overwhelm small inventors with repeated litigation, says Eb Bright at ExploraMed Development.

  • Changes Coming To The SBIR And STTR Programs

    Author Photo

    Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.

  • Witness AI Usage Is The Next Privilege Battle In Civil Litigation

    Author Photo

    Fact and expert witnesses now have immediate access to artificial intelligence systems capable of simulating deposition questioning, recommending answers and more, but this preparation occurs privately, invisibly and frequently under the mistaken assumption that it is harmless, says Bill Kanasky at Courtroom Sciences and Billy Davis at Taylor Nelson.

  • Moderna Case Highlights Overlooked Hurdle In Biopharma IP

    Author Photo

    The recent settlement of the patent litigation involving Moderna's COVID-19 vaccine in Delaware federal court shows that patent portfolios covering enabling platform technologies can create significant freedom-to-operate risk even when their owners are not direct competitors developing the therapeutic product, says Olga Berson at Thompson Coburn.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.